Related Experiment Video
Updated: Mar 18, 2026

12:03
Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
8.3K
Small Activating RNAs: Delivery and Therapeutic Applications in Disease Treatment
Herath Mudiyanselage Pramod Theekshana1, Luyun Ni1, Yuxin Zhong1
1Department of Pharmaceutics, School of Pharmacy, Nantong University, Nantong 226001, China.
Molecular Pharmaceutics
|March 16, 2026
Summary
Small activating RNAs (saRNAs) offer a novel therapeutic approach by upregulating gene expression for undruggable diseases. This RNA activation mechanism shows promise for cancer treatment and beyond.
Area of Science:
- Molecular Biology
- Epigenetics
- Drug Discovery
Background:
- RNA oligonucleotides are emerging as key therapeutic tools for diseases untreatable by conventional methods.
- Small activating RNAs (saRNAs) are synthetic dsRNAs that upregulate gene expression via RNA activation.
- RNA activation is a conserved mechanism across eukaryotes, targeting gene promoters at transcriptional and epigenetic levels.
Purpose of the Study:
- To review the current literature on saRNA biology.
- To focus on saRNA characteristics, mechanisms, challenges, and therapeutic potential.
- To explore future applications of saRNAs in disease treatment.
Main Methods:
- Review of current scientific literature on saRNA.
- Analysis of saRNA characteristics and mechanisms of action.
- Evaluation of delivery systems for in vivo saRNA application.
Main Results:
- saRNAs function as regulatory molecules to upregulate endogenous gene expression.
- RNA activation involves targeting gene promoters at transcriptional and epigenetic levels.
- Effective in vivo delivery systems facilitate saRNA-mediated transcription activation.
Conclusions:
- saRNAs represent a promising therapeutic strategy for cancer and other diseases.
- Further research into saRNA biology and delivery is warranted.
- saRNAs hold significant potential for future therapeutic applications.
Related Concept Videos
Experimental RNAi
8.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.2K
siRNA - Small Interfering RNAs
19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
RNA Interference
7.8K
7.8K
RNA Interference
28.4K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.4K
Small interfering RNAs (siRNA)
5.2K
5.2K
MicroRNAs
4.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K

